Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Luc Janssens Added: 3 years ago
Chronic heart disease is the leading cause of death in both men and women in the US, and coronary artery disease (CAD) constitutes the number one cause among them. Acute ST-segment-elevation myocardial infarction (STEMI) usually occurs when a thrombus forms on a ruptured atheromateus plaque and occludes an epicardial coronary artery. Patient survival depends on several factors, the most important… View more
Author(s): Pedro L Sánchez , Isaac Pascual Calleja , Héctor Bueno , et al Added: 3 years ago
The results of an electrocardiogram (ECG) on admission guide the next level of decision-making for the patient with chest pain suspected of myocardial ischaemia. If an occlusive thrombus forms, patients may develop an acute ST-segment-elevation myocardial infarction (STEMI), and the primary goal is to consider reperfusion therapy as quickly as possible. The benefit obtained by effective and early… View more
Author(s): Juan Tamargo Added: 3 years ago
“When the cause of the sickness is unknown, only a miracle can cure it.” Don Quixote, Miguel de Cervantes, 1605. The coronavirus 2019 (COVID-19) pandemic was caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2 COVID-19 rapidly spread from China to most countries around the world, and on 11 March 2020 the WHO declared a global pandemic. The COVID-19… View more
Author(s): Athanasios Koutsoukis , Argyrios Ntalianis , Evangelos Repasos , et al Added: 3 years ago
Cardio-oncology is an emerging field of cardiology that focuses on cardiovascular diseases in patients with cancer. The classic cardio-oncology paradigm is the prevention, diagnosis and treatment of cardiotoxicity resulting from chemotherapy and/or radiotherapy. Diagnosis and treatment of primary and metastatic cardiac tumours as well as cardiac amyloidosis can be considered ‘less classical’… View more
Author(s): Brian A Bruckner , Matthias Loebe Added: 3 years ago
The use of mechanical circulatory assist devices is rapidly expanding. Patients in advanced stages of heart failure are implanted with support devices, allowing them to regain a fairly normal level of activity. Presently, more then 3,500 patients live with a left ventricular assist device (LVAD). The numbers of patients supported with biventricular assist devices or total artificial hearts is… View more
Author(s): Marco Metra , Savina Nodari , Livio Dei Cas Added: 3 years ago
Beta-blocker therapy remains one of the most fascinating issues in heart failure (HF) clinical practice. These agents, once absolutely contraindicated in patients with HF, have been shown to have the greatest beneficial effects on the patients' prognosis. They have radically changed the clinical course of HF, more than any other agent previously introduced, and are now the cornerstone of current… View more
Author(s): Andreas H Mahnken , Joachim E Wildberger , Peter R Seidensticker Added: 3 years ago
Coronary artery disease (CAD) represents a relevant economic burden to modern medicine. In 2003 more than 1.41 million diagnostic coronary angiograms and an additional 1.24 million percutaneous coronary angioplasties were performed in the US alone.1 While coronary angiography is considered the gold standard for diagnosing CAD, several non-invasive techniques have been evaluated for assessing CAD… View more
Author(s): Marco Metra , Savina Nodari , Livio Dei Cas Added: 3 years ago
Beta-blocker therapy remains one of the most fascinating issues in heart failure (HF) clinical practice. These agents, once absolutely contraindicated in patients with HF, have been shown to have the greatest beneficial effects on the patients' prognosis. They have radically changed the clinical course of HF, more than any other agent previously introduced, and are now the cornerstone of current… View more
Author(s): Eva Goncalvesova Added: 3 years ago
Abstract Pulmonary arterial hypertension (PAH) is a progressive and debilitating disease with poor prognosis and limited therapeutic options. While currently available PAH treatments can provide substantial clinical benefits, they are not curative. The efficacy of prostanoid treatment in PAH is well-established in clinical trials, open-label and long-term observational studies, and prostanoid… View more
Added: 2 years ago Source:  EchoNous
A portable heart scanner which uses breakthrough artificial intelligence is solving reproducibility and repeatability issues in echocardiography, enabling clinicians to diagnose heart failure more quickly whilst also shortening exam times. Renowned cardiologists say that as well as helping to save time - enabling them to see more patients and reducing waiting times - it tackles the long… View more